Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk

Lawrence D. Lazar; A. Michael Lincoff

doi:10.3949/ccjm.76a.09116

Current Drug Therapy

Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk

Lawrence D. Lazar, MD and A. Michael Lincoff, MD

Cleveland Clinic Journal of Medicine December 2009, 76 (12) 707-714; DOI: https://doi.org/10.3949/ccjm.76a.09116

Lawrence D. Lazar

Department of Cardiovascular Medicine, Cleveland Clinic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: lazarl@ccf.org

A. Michael Lincoff

Professor of Medicine; Vice Chairman, Department of Cardiovascular Medicine

Director, Center for Clinical Research, Lerner Research Institute

Director, Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

Article Information

vol. 76 no. 12 707-714

DOI

https://doi.org/10.3949/ccjm.76a.09116

PubMed

19952295

Published By

Cleveland Clinic Journal of Medicine

Print ISSN

0891-1150

Online ISSN

1939-2869

History

Published online December 1, 2009.

Cited By...

9 Citations
Google Scholar

PreviousNext

In this issue

Cleveland Clinic Journal of Medicine

Vol. 76, Issue 12

1 Dec 2009

Table of Contents
Table of Contents (PDF)
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk

Message Subject (Your Name) has sent you a message from Cleveland Clinic Journal of Medicine

Message Body (Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk

Lawrence D. Lazar, A. Michael Lincoff

Cleveland Clinic Journal of Medicine Dec 2009, 76 (12) 707-714; DOI: 10.3949/ccjm.76a.09116

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk

Lawrence D. Lazar, A. Michael Lincoff

Cleveland Clinic Journal of Medicine Dec 2009, 76 (12) 707-714; DOI: 10.3949/ccjm.76a.09116

Share This Article:

Tweet Widget
Facebook Like
Linkedin Share Button

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Prasugrel is effective and safe for neurointerventional procedures

Google Scholar

Main menu

User menu

Search

Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk

Article Information

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

Authors & Reviewers